As of 8:00:44 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
723,549.00
644,395.00
498,987.00
437,768.00
349,846.00
Cost of Revenue
340,202.00
293,274.00
250,127.00
238,029.00
206,506.00
Gross Profit
383,347.00
351,121.00
248,860.00
199,739.00
143,340.00
Operating Expense
169,092.00
154,134.00
141,363.00
129,852.00
132,386.00
Operating Income
214,255.00
196,987.00
107,497.00
69,887.00
10,954.00
Net Non Operating Interest Income Expense
-22,751.00
-21,699.00
-525.00
-284.00
268.00
Other Income Expense
-4,357.00
-3,929.00
9,068.00
14,536.00
-6,585.00
Pretax Income
187,147.00
171,359.00
116,040.00
84,139.00
4,637.00
Tax Provision
28,347.00
31,833.00
23,477.00
20,630.00
3,540.00
Earnings from Equity Interest Net of Tax
-1,078.00
-1,981.00
-1,177.00
-208.00
--
Net Income Common Stockholders
157,722.00
137,545.00
91,386.00
62,116.00
1,403.00
Diluted NI Available to Com Stockholders
157,722.00
137,545.00
91,386.00
62,116.00
1,403.00
Basic EPS
3.25
2.85
1.88
1.30
0.03
Diluted EPS
3.01
2.60
1.74
1.25
0.03
Basic Average Shares
48,424.00
48,265.00
48,551.00
47,777.00
47,038.00
Diluted Average Shares
52,483.50
53,001.00
52,427.00
49,784.00
49,124.00
Total Operating Income as Reported
214,255.00
196,987.00
107,497.00
69,887.00
10,954.00
Total Expenses
509,294.00
447,408.00
391,490.00
367,881.00
338,892.00
Net Income from Continuing & Discontinued Operation
157,722.00
137,545.00
91,386.00
62,116.00
1,403.00
Normalized Income
157,722.00
137,545.00
91,386.00
62,116.00
1,403.00
Interest Income
10,623.00
5,459.00
1,321.00
601.00
642.00
Interest Expense
33,374.00
27,158.00
1,846.00
885.00
374.00
Net Interest Income
-22,751.00
-21,699.00
-525.00
-284.00
268.00
EBIT
220,521.00
198,517.00
117,886.00
85,024.00
5,011.00
EBITDA
276,851.00
240,294.00
146,161.00
111,557.00
30,191.00
Reconciled Cost of Revenue
340,202.00
293,274.00
250,127.00
238,029.00
206,506.00
Reconciled Depreciation
56,330.00
41,777.00
28,275.00
26,533.00
25,180.00
Net Income from Continuing Operation Net Minority Interest
157,722.00
137,545.00
91,386.00
62,116.00
1,403.00
Normalized EBITDA
276,851.00
240,294.00
146,161.00
111,557.00
30,191.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 3/4/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
068760.KQ Celltrion Pharm, Inc.
56,900.00
-1.22%
27N0.DU Cannovum Cannabis AG
0.5000
+0.40%
0ET.MU Esperion Therapeutics Inc
2.1410
0.00%
CRFTF BC Craft Supply Co. Ltd.
0.0001
0.00%
11L.MU Canopy Growth Corp. R
2.5700
-0.39%
RIG2.BE Chemical Works of Gedeon Richter PLC
25.16
-0.55%
R9U2.F Green Thumb Industries Inc.
7.42
+2.77%
KN0.F Dicot Pharma AB
0.0282
+20.00%
CEL.L Celadon Pharmaceuticals Plc
14.00
-12.50%
9989.HK Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
3.640
-2.93%